UNITED THERAPEUTICS (UTHR) Covered Calls

UNITED THERAPEUTICS covered calls United Therapeutics Corporation is a biotechnology company is focused on the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening cardiovascular and infectious diseases and cancer.

You can sell covered calls on UNITED THERAPEUTICS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for UTHR (prices last updated Tue 4:16 PM ET):

UNITED THERAPEUTICS (UTHR) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
127.04 +3.62 127.04 139.00 253K 7.5 5.4B
Covered Calls For UNITED THERAPEUTICS (UTHR)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Oct 19 125 2.05 136.95 -8.7% -793.9%
Nov 16 125 6.70 132.30 -5.5% -62.7%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

United Therapeutics Corp. operates as a biotechnology company, which focuses on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening cardiovascular and infectious diseases and cancer. The company operates in two business segments: Pharmaceuticals and Telemedicine. Its primary product Remodulin is used for the treatment of pulmonary arterial hypertension and the company also develops glycol-biological antiviral agents for the treatment of infectious diseases, such as Hepatitis C. United Therapeutics was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.